SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001082554-21-000018
Filing Date
2021-05-05
Accepted
2021-05-05 06:17:25
Documents
16
Period of Report
2021-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K uthr-20210505.htm   iXBRL 8-K 38001
2 EX-99.1 uthrq12021-ex991.htm EX-99.1 208277
8 GRAPHIC red_topper31.gif GRAPHIC 143263
  Complete submission text file 0001082554-21-000018.txt   605321

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20210505.xsd EX-101.SCH 2458
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20210505_cal.xml EX-101.CAL 744
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20210505_def.xml EX-101.DEF 1689
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20210505_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20210505_pre.xml EX-101.PRE 12680
9 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20210505_htm.xml XML 10794
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 21891050
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences